Eva Brix

Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial

Miguel Martín, Frankie A. Holmes, Bent Ejlertsen et al. · The Lancet Oncology · 2017 · 578 citations

5-Year Analysis, Breast Oncology, Oncology +10

The mode of delivery in patients with preeclampsia at term subject to elective or emergency Cesarean section

Juliane Pacher, Eva Brix, Rainer Lehner · Archives of Gynecology and Obstetrics · 2013 · 26 citations

Cesarean Health, Abortion, Preterm Labor +12

Facial Rejuvenation with Concentrated Lipograft—A 12 Month Follow-Up Study

Lukas Prantl, Eva Brix, Sally Kempa et al. · Cells · 2021 · 26 citations · Full text

Autologous fat grafting for breast reconstruction after breast cancer: a 12-year experience

Sally Kempa, Eva Brix, Norbert Heine et al. · Archives of Gynecology and Obstetrics · 2021 · 25 citations · Full text

Adipose Tissue-Derived Stem Cell Yield Depends on Isolation Protocol and Cell Counting Method

Lukas Prantl, Andreas Eigenberger, Eva Brix et al. · Cells · 2021 · 22 citations · Full text

Tissue Engineering, Cell Counting Method, Engineering +19